Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 880 studies with search of: | United States, Delaware |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
|
||||
2 | Active, not recruiting |
Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza
|
||||
3 | Active, not recruiting |
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
|
||||
4 | Active, not recruiting |
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
|
||||
5 | Recruiting |
Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
|
||||
6 | Active, not recruiting |
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
|
||||
7 | Active, not recruiting |
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
|
||||
8 | Active, not recruiting |
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
|
||||
9 | Active, not recruiting |
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
|
||||
10 | Completed |
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
|
||||
11 | Recruiting |
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
||||
12 | Active, not recruiting |
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
|
||||
13 | Recruiting |
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
|
||||
14 | Active, not recruiting |
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
|
||||
15 | Completed |
FR901228 in Treating Patients With Recurrent Small Cell Lung Cancer
|
||||
16 | Active, not recruiting |
Sorafenib in Treating Patients With Malignant Mesothelioma
|
||||
17 | Completed |
Combination Chemotherapy in Treating Patients With Bladder Cancer
|
||||
18 | Recruiting |
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
|
||||
19 | Recruiting |
Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
|
||||
20 | Recruiting |
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |